A Survey of Hepatitis B Virus and Hepatitis E Virus at the Human-Wildlife Interface in the Peruvian Amazon

Microorganisms. 2024 Sep 10;12(9):1868. doi: 10.3390/microorganisms12091868.

Abstract

Hepatitis B virus (HBV) and Hepatitis E virus (HEV) are zoonotic pathogens posing significant health concerns in rural Amazonia, a region marked by high endemicity, poverty, and limited healthcare access. However, the epidemiology of HBV and HEV in this ecosystem remains underexplored. This study examines the circulation of HBV and HEV at the human-wildlife interface and identifies risk factors within an isolated Amazonian indigenous community reliant on hunting for subsistence. Antibodies against HBV core antigens (HBcAbs) were found in three wildlife species: Cuniculus paca (0.8%), Tayassu pecari (1.6%), and Mazama americana (4.1%), marking the first record of HBV antibodies in free-ranging wildlife in the Amazon. However, further research is necessary to identify circulating strains and their relation to human HBV. HBcAbs were also detected in 9.1% of human samples, confirming exposure to HBV in the region. HEV IgG antibodies were present in 17.1% of humans and were associated with higher age. All wildlife and domestic animal samples tested negative for HEV, but transmission through consumption of wild animals and contaminated water needs further investigation. The identified risk factors highlight the urgent need for measures to promote safer food handling, improved sanitation, hygiene, and practices related to contact with wild animals.

Keywords: HBV; HEV; epidemiology; hepatitis; one health; risk factors; tropical forests.

Grants and funding

This work was supported by ERANet-LAC (ERANet17/HLH-0271), research projects (nº 136-2018-FONDECYT; AC18/00054 Instituto de Salud Carlos; 400800/2019-5 CNPq), Fundació Autònoma Solidària (n° FS-XXXVI-FS1) y Global GreenGrants Funds (n° 2020-4226), and the training grant D43 TW007393 awarded by the Fogarty International Center of the US National Institutes of Health, who also supported MLS and AGL. M.F.M. acknowledges a doctoral scholarship from the Catalan Agency for Management of University and Research Grants [scholarship FI-SDUR EMC/3345/2020] and received the funding from the Royal Society of Tropical Medicine and Hygiene (RSTMH) as part of a small research grant initiative “https://www.rstmh.org/grants/grant-awardees-2021 (accessed on 7 September 2024)”. GU received two grants from the CNPq PPGSPAA program in GD modality (140312/2020-0) and SWE modality (201546/2020-5).